{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:02:30Z","timestamp":1782514950129,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17015016"],"award-info":[{"award-number":["17015016"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18790457"],"award-info":[{"award-number":["18790457"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.cbi.2009.07.015","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T12:01:10Z","timestamp":1249041670000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["(\u2212)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFR\u03b2 and IGF-1R"],"prefix":"10.1016","volume":"182","author":[{"given":"Yoichi","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2009.07.015_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2009.07.015_bib2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2009.07.015_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/gut.2003.030353","article-title":"Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C","volume":"53","author":"Yoshida","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2009.07.015_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2009.07.015_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jhep.2007.01.029","article-title":"Pro-fibrogenic potential of PDGF-D in liver fibrosis","volume":"46","author":"Borkham-Kamphorst","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2009.07.015_bib6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI117497","article-title":"Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture","volume":"94","author":"Wong","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2009.07.015_bib7","first-page":"785","article-title":"Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis","volume":"148","author":"Pinzani","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2009.07.015_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.pharmtox.42.082101.154309","article-title":"Inhibition of carcinogenesis by tea","volume":"42","author":"Yang","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2009.07.015_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1158\/1078-0432.CCR-04-2014","article-title":"(\u2212)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells","volume":"11","author":"Shimizu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2009.07.015_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1940-6207.CAPR-08-0045","article-title":"(\u2212)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL\/KsJ-db\/db mice","volume":"1","author":"Shimizu","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.cbi.2009.07.015_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2007.11.026","article-title":"EGCG inhibits activation of the insulin-like growth factor (IGF)\/IGF-1 receptor axis in human hepatocellular carcinoma cells","volume":"262","author":"Shimizu","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2009.07.015_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(00)01360-0","article-title":"Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma","volume":"471","author":"Sachinidis","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2009.07.015_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/labinvest.3700426","article-title":"Crosstalk between PDGF and IGF-I receptors in rat liver myofibroblasts: implication for liver fibrogenesis","volume":"86","author":"Novosyadlyy","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cbi.2009.07.015_bib14","doi-asserted-by":"crossref","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats","volume":"288","author":"Yoshiji","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2009.07.015_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2007.06.017","article-title":"Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1beta","volume":"47","author":"Ogiso","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2009.07.015_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/jhep.2001.22650","article-title":"Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis","volume":"33","author":"Shimizu","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2009.07.015_bib17","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1158\/0008-5472.CAN-06-4025","article-title":"Development of gastric tumors in Apc(Min\/+) mice by the activation of the beta-catenin\/Tcf signaling pathway","volume":"67","author":"Tomita","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2009.07.015_bib18","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1167\/iovs.06-0407","article-title":"Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice","volume":"47","author":"Kociok","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cbi.2009.07.015_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2108\/zsj.20.441","article-title":"Changes in the mRNA expressions of insulin-like growth factors, their receptors, and binding proteins during the postnatal development of rat masseter muscle","volume":"20","author":"Saito","year":"2003","journal-title":"Zoolog. Sci."},{"key":"10.1016\/j.cbi.2009.07.015_bib20","doi-asserted-by":"crossref","first-page":"23381","DOI":"10.1074\/jbc.M212042200","article-title":"The antioxidant (\u2212)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factor-beta receptor","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2009.07.015_bib21","first-page":"69","article-title":"EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells","volume":"5","author":"Shimizu","year":"2005","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.cbi.2009.07.015_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/excr.1994.1101","article-title":"Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene","volume":"211","author":"Rubini","year":"1994","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cbi.2009.07.015_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lab.2005.12.009","article-title":"Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells","volume":"147","author":"Bridle","year":"2006","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cbi.2009.07.015_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jnutbio.2006.12.016","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis","volume":"18","author":"Zhen","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.cbi.2009.07.015_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3164\/jcbn.08-256","article-title":"Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis","volume":"44","author":"Nakamoto","year":"2009","journal-title":"J. Clin. Biochem. Nutr."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279709003056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279709003056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:20:28Z","timestamp":1757856028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279709003056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":25,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0009279709003056"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2009.07.015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(\u2212)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFR\u03b2 and IGF-1R","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2009.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}